Home/Filings/4/0001628280-24-025219
4//SEC Filing

Fuhrman Alan 4

Accession 0001628280-24-025219

CIK 0001434868other

Filed

May 23, 8:00 PM ET

Accepted

May 24, 4:17 PM ET

Size

20.0 KB

Accession

0001628280-24-025219

Insider Transaction Report

Form 4
Period: 2024-05-23
Fuhrman Alan
Director
Transactions
  • Award

    Stock Option (right to buy)

    2024-05-23+32,50032,500 total
    Exercise: $2.25Exp: 2034-05-23Common Stock (32,500 underlying)
  • Award

    Common Stock

    2024-05-23+23,00053,404 total
Footnotes (1)
  • [F1]The awards vest in full on the earlier of (i) May 23, 2025 and (ii) the Issuer's next annual meeting of stockholders following May 23, 2024.

Issuer

Esperion Therapeutics, Inc.

CIK 0001434868

Entity typeother

Related Parties

1
  • filerCIK 0001303521

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 4:17 PM ET
Size
20.0 KB